Predicting Acute and Persistent Neuropathy Associated With Oxaliplatin

Abstract

Routinely available clinical factors predict acute and persistent neuropathy associated with oxaliplatin. When validated, the proposed prognostic score for persistent neuropathy can help clinicians counsel patients about chemotherapy.